Cargando…

Repurposing of Empagliflozin as a Possible Treatment for Neutropenia and Inflammatory Bowel Disease in Glycogen Storage Disease Type Ib: A Case Report

Glycogen storage disease type Ib (GSD-Ib) is an autosomal-recessive inborn error of carbohydrate metabolism, where severe fasting hypoglycemia is associated (among other manifestations) with neutropenia and neutrophil dysfunction (predisposing to recurrent, potentially life-threatening infections) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makrilakis, Konstantinos, Barmpagianni, Aikaterini, Veiga-da-Cunha, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403211/ https://www.ncbi.nlm.nih.gov/pubmed/36039216 http://dx.doi.org/10.7759/cureus.27264

Ejemplares similares

Untargeted metabolomic profiling in a patient with glycogen storage disease Ib receiving empagliflozin treatment
por: Tallis, Eran, et al.
Publicado: (2022)

Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib
por: Grünert, Sarah C., et al.
Publicado: (2020)

Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report
por: Rossi, Alessandro, et al.
Publicado: (2021)

Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib
por: Grünert, Sarah Catharina, et al.
Publicado: (2022)

Patient‐reported outcomes on empagliflozin treatment in glycogen storage disease type Ib: An international questionnaire study
por: Grünert, Sarah C., et al.
Publicado: (2023)

The overall benefits of empagliflozin treatment in adult siblings with glycogen storage disease type Ib: one year experience
por: Bidiuk, Joanna, et al.
Publicado: (2022)

Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patients
por: Hexner-Erlichman, Zufit, et al.
Publicado: (2022)

Crohn-like disease long remission in a pediatric patient with glycogen storage disease type Ib treated with empagliflozin: a case report
por: Calia, Margherita, et al.
Publicado: (2023)

Liver transplantation in glycogen storage disease type Ib: The role of SGLT2 inhibitors
por: Murko, Simona, et al.
Publicado: (2023)

Genotypic and phenotypic characteristics of 12 chinese children with glycogen storage diseases
por: Dong, Rui, et al.
Publicado: (2022)

Glycogen Storage Disease Ib and Severe Periodontal Destruction: A Case Report
por: Ma, Rui, et al.
Publicado: (2018)

Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation
por: Melis, Daniela, et al.
Publicado: (2015)

Determining mutations in G6PC and SLC37A4 genes in a sample of Brazilian patients with glycogen storage disease types Ia and Ib
por: Carlin, Marcelo Paschoalete, et al.
Publicado: (2013)

The natural history of glycogen storage disease type Ib in England: A multisite survey
por: Halligan, Rebecca, et al.
Publicado: (2021)

Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: new insights coming from diabetes for its potential implications in other metabolic disorders
por: Maiorana, Arianna, et al.
Publicado: (2023)

Case report: Familial glycogen storage disease type IV caused by novel compound heterozygous mutations in a glycogen branching enzyme 1 gene
por: Li, Yiyang, et al.
Publicado: (2022)

Novel SLC37A4 Mutations in Korean Patients With Glycogen Storage Disease Ib
por: Choi, Rihwa, et al.
Publicado: (2017)

Infectious and digestive complications in glycogen storage disease type Ib: Study of a French cohort
por: Wicker, Camille, et al.
Publicado: (2020)

A novel mutation in SLC37A4 gene in a Sri Lankan boy with glycogen storage disease type Ib associated with very early onset neutropenia
por: Dissanayake, Vajira HW, et al.
Publicado: (2011)

Clinical Remission of Severe Crohn’s Disease with Empagliflozin Monotherapy in a Pediatric Patient with Glycogen Storage Disease Type 1b
por: Collen, Lauren V., et al.
Publicado: (2023)

Mutation analysis of SLC37A4 in a patient with glycogen storage disease-type Ib
por: Zhang, Yamei, et al.
Publicado: (2019)

Clinical analysis and long-term treatment monitoring of 3 patients with glycogen storage disease type Ib
por: Du, Caiqi, et al.
Publicado: (2021)

A Novel Lipoprotein Lipase Mutation in an Infant With Glycogen Storage Disease Type-Ib and Severe Hypertriglyceridemia
por: Wang, Fengyu, et al.
Publicado: (2021)

From common to rare: repurposing of bempedoic acid for the treatment of glycogen storage disease type 1
por: Das, Anibh M.
Publicado: (2023)

Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre
por: Halligan, Rebecca K., et al.
Publicado: (2022)

Novel AGL variants in a patient with glycogen storage disease type IIIb and pulmonary hypertension caused by pulmonary veno-occlusive disease: A case report
por: Shindo, Akito, et al.
Publicado: (2023)

Glycogen storage diseases: An update
por: Gümüş, Ersin, et al.
Publicado: (2023)

Co-occurrence of Glycogen Storage Disease Type 2 and Congenital Myasthenic Syndrome Type 5 in a Pediatric Patient: A Case Report
por: Al-Sharif, Fawzia, et al.
Publicado: (2022)

Next-generation glycogen storage diseases
por: Derks, Terry G. J., et al.
Publicado: (2018)

Biomarkers in Glycogen Storage Diseases: An Update
por: Molares-Vila, Alberto, et al.
Publicado: (2021)

Whole-Exome Sequencing Uncovers Novel Causative Variants and Additional Findings in Three Patients Affected by Glycogen Storage Disease Type VI and Fanconi−Bickel Syndrome
por: Eghbali, Maryam, et al.
Publicado: (2021)

Successful use of empagliflozin to treat neutropenia in two G6PC3‐deficient children: Impact of a mutation in SGLT5
por: Boulanger, Cécile, et al.
Publicado: (2022)

Very early-onset inflammatory bowel disease: Novel description in glycogen storage disease type Ia
por: Hannah, William B., et al.
Publicado: (2022)

Minimally invasive surgery for glycogen storage disease combined with inflammatory bowel disease: A case report
por: Wan, Jian, et al.
Publicado: (2021)

Sodium‐glucose cotransporter type 2 channel inhibitor: Breakthrough in the treatment of neutropenia in patients with glycogen storage disease type 1b?
por: Kaczor, Magdalena, et al.
Publicado: (2022)

ON THE DIFFERING APPEARANCE OF INTRANUCLEAR AND CYTOPLASMIC GLYCOGEN IN LIVER CELLS IN GLYCOGEN STORAGE DISEASE
por: Sheldon, H., et al.
Publicado: (1962)

Glycogen storage disease presenting as Cushing syndrome
por: Stefater, Margaret A., et al.
Publicado: (2019)

Neurological Characteristics of Pediatric Glycogen Storage Disease
por: Muzetti, Julio Henrique, et al.
Publicado: (2021)

A case of secondary acute myeloid leukemia on a background of glycogen storage disease with chronic neutropenia treated with granulocyte colony stimulating factor
por: Khalaf, Dina, et al.
Publicado: (2019)

Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases
por: Challa, Anup P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qev0imscrps11l0stbd5qrkbs5